Jonathan Alicea

Reductions in prescribed benzodiazepines were especially noted in continuing prescriptions.

The cohort study is the first to report developmental cascades between disturbed sleep and depressive symptoms throughout childhood and early adolescence.

Patients over 21 years who developed acne presented with different clinical characteristics than younger patients.

A systematic literature review identifies 41 unique definitions for psoriasis remission among 106 studies.

Previous smaller studies have suggested a link between sleep disorders and dementia.

MBTI was effective in reducing sleep onset latency discrepancy but not wake after sleep onset discrepancy.

Patients with obstructive sleep apnea who sleep between 22:00 PM and 5:59 AM had higher incidences of acute myocardial infarction and chest pains, a new study observes.

The bioactive triterpenoid saponin was associated with edema in treated patients.

Investigators in a new multicenter study observed poor vaccine-induced serological responses in patients treated with infliximab or tofacitinib.

Patients who demonstrated high trough concentrations early on in treatment were more likely to achieve remission by weeks 14 or 52.

Subcutaneous administration of the gut-selective treatment was notably well-tolerated, safe, and cost-effective.

According to a claims analysis, sunburn was also commonly diagnosed in female and young patients.

Women with COVID-19 who gave birth were more likely to deliver earlier than 37 weeks.

Niemann-Pick is highly heterogenous and is characterized by hypervariable manifestations across patients.

The prevalence of striae distensae was notably higher in psoriasis than atopic dermatitis.

Patients with 360° catheter-assisted trabeculotomy had the best success rates.

Excessive hemolysis and genetic factors may be associated with cholelithiasis.

A sickle cell expert discusses the shifting therapeutic landscape as well as a need to rethink hemoglobin level threshold guidelines for patients.

Patients who reported neurocognitive challenges were more likely to have reduced skills related to instrumental activities of daily living.

Brett King, MD, PhD, encourages dermatologists to wait for more clinical data before making any assumptions on the drug class' safety and selectivity.

Outlook Therapeutics anticipates submitting a Biologics License Application to the FDA as early as next year.

Brett King, MD, PhD, compares the efficacy of JAKs with biologics in the atopic dermatitis setting.

Sharon Hrynkow, PhD, joins the Rare Disease Report to discuss the ultra rare and heterogenous lysosomal storage disorder.

Brett King, MD, PhD, provides an overview of JAK inhibitors and their interaction with the JAK-STAT pathway.

The first-in-class monoclonal antibody is the first therapeutic expansion for this patient population in over 10 years.

Previous research has shown that COVID-19 can impact ocular health.

Studies are needed to determine the best treatment regimen for these patients.

OnabotulinumtoxinA treatment may now include 8 new muscles.

OCTA can be used as a support technique to improve patient flow and reduce number of fluorescein angiography.

Treatment was associated with reductions in IGA scores as well as inflammatory and non-inflammatory lesion counts.